Coincidently the expression of Ki67 pro-proliferative factor is highly down regulated in tumour cells of animal group treated with A-EMHVs-MF, suggesting that reprogramming of the tumour suppressor gene methylation might take place and re-establishing chemotherapy sensitivity would prompt those cancer cells to respond to a subsequent conventional chemotherapy. The gene discussed is MKI67; the disease is neoplasm.